| 今开：4.99 | 昨收：5.05 |
| 最高：5.05 | 最低：4.905 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.13528077E8 |
Allogene疗法(ALLO)2020-10-17 07:33
$Allogene疗法(ALLO)$ 内部交易: 2020-10-15,CFO,SCHMIDT ERIC THOMAS ,卖出,15000普通股, $40.49查看全文
Allogene疗法(ALLO)2020-10-09 05:18
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-008508 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)2020-10-10 07:33
$Allogene疗法(ALLO)$ 内部交易: 2020-10-09,Chief Technical Officer,MOORE ALISON ,卖出,39509普通股, $41.00查看全文
Allogene疗法(ALLO)2020-10-14 07:36
$Allogene疗法(ALLO)$ 内部交易: 2020-10-13,Chief Technical Officer,MOORE ALISON ,卖出,11031普通股, $42.00查看全文
Allogene疗法(ALLO)2020-10-09 05:06
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-008506 Size: 8 KB 网页链接查看全文
Allogene疗法(ALLO)2020-10-09 05:06
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-20-008504 Size: 8 KB 网页链接查看全文
Allogene疗法(ALLO)2020-10-09 07:34
$Allogene疗法(ALLO)$ 内部交易: 2020-10-06,General Counsel,Bhavnagri Veer ,卖出,10000普通股, $40.00查看全文
Allogene疗法(ALLO)2020-10-09 07:34
$Allogene疗法(ALLO)$ 内部交易: 2020-10-06,General Counsel,Bhavnagri Veer ,期权,10000普通股, $2.27查看全文
Allogene疗法(ALLO)2020-10-10 07:33
$Allogene疗法(ALLO)$ 内部交易: 2020-10-08,Chief Technical Officer,MOORE ALISON ,卖出,5065普通股, $41.00查看全文
Allogene疗法(ALLO)2020-10-14 07:36
$Allogene疗法(ALLO)$ 内部交易: 2020-10-13,Chief Technical Officer,MOORE ALISON ,期权,11031普通股, $2.27查看全文
Allogene疗法(ALLO)03-17 05:36
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 05:12
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 04:57
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-17 04:51
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接查看全文
Allogene疗法(ALLO)03-11 05:06
$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接查看全文
Allogene疗法(ALLO)03-01 05:36
$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接查看全文
Allogene疗法(ALLO)03-01 05:27
$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接查看全文
Allogene疗法(ALLO)03-01 05:12
$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接查看全文
Allogene疗法(ALLO)02-15 06:18
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接查看全文
Allogene疗法(ALLO)02-14 05:36
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接查看全文
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接
$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接
$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接
$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接
$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接
$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接
$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接